Natural Biocon (India) quarterly results and financials

Natural Biocon (India) (BSE 543207)₹2.44+3.39%(9 Nov 2026 close)Pesticides & Agrochemicals

Key facts

In the Mar 2026 quarter (standalone), Natural Biocon (India) reported sales of ₹0.89 Cr, down 34.6% from Mar 2025, and net profit of −₹0.10 Cr. For the year to Mar 2026, sales were ₹2.56 Cr and net profit −₹0.05 Cr.

Sales (Mar 2026): ₹0.89 Cr
Net profit (Mar 2026): −₹0.10 Cr
Sales (FY Mar 2026): ₹2.56 Cr
Net profit (FY Mar 2026): −₹0.05 Cr
EPS (Mar 2026): ₹−0.04
Borrowings (Mar 2026): ₹0.39 Cr

Company filings, standalone accounts; latest reported quarter Mar 2026

Natural Biocon (India) quarterly results

₹ crore unless stated; each column is a quarter.

Natural Biocon (India) Quarterly results
	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales	0.28	3.25	2.17	11.39	1.00	4.75	1.29	1.36	1.68	0.00	0.00	0.89
Expenses	0.23	3.11	2.08	11.28	0.90	4.55	1.04	1.85	1.54	0.05	0.05	0.98
Operating Profit	0.06	0.15	0.10	0.14	0.11	0.21	0.26	−0.50	0.15	−0.05	−0.05	−0.10
OPM %	18.6%	4.3%	4.2%	1.2%	10.1%	4.2%	19.5%	−36.3%	8.4%	—	—	−10.2%
Other Income	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Profit before tax	0.04	0.13	0.08	0.12	0.09	0.19	0.24	−0.48	0.13	−0.03	−0.03	−0.08
Tax %	0.0%	0.0%	22.1%	53.8%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net Profit	0.06	0.15	0.09	0.07	0.11	0.21	0.26	−0.50	0.15	−0.05	−0.05	−0.10
EPS (Rs)	0.05	0.13	0.08	0.06	0.10	0.09	0.11	−0.20	0.06	−0.03	−0.03	−0.04

Natural Biocon (India) profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Natural Biocon (India) Profit and loss
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	0.06	0.16	1.05	0.46	0.00	0.14	0.49	1.26	13.55	8.36	2.56	2.57
Expenses	0.06	0.05	0.05	0.35	0.04	0.14	0.40	1.01	13.35	8.32	2.60	2.62
Operating Profit	0.00	0.12	1.01	0.12	−0.04	0.00	0.10	0.26	0.24	0.07	−0.05	−0.05
OPM %	0.0%	73.4%	96.2%	24.4%	—	0.0%	18.8%	20.0%	1.7%	0.7%	−1.6%	−2.0%
Other Income	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Profit before tax	0.00	0.10	0.99	0.11	−0.02	0.00	0.08	0.24	0.22	0.05	−0.03	−0.01
Tax %	—	27.2%	29.9%	41.6%	166.6%	—	22.2%	28.0%	30.4%	33.3%	0.0%	—
Net Profit	0.00	0.09	0.71	0.08	−0.09	0.00	0.08	0.19	0.16	0.05	−0.05	−0.05
EPS (Rs)	0.00	0.08	0.63	0.07	−0.08	0.00	0.07	0.17	0.14	0.03	−0.03	−0.04
Dividend payout %	—	0.0%	0.0%	81.2%	0.0%	—	0.0%	0.0%	0.0%	0.0%	0.0%	—

Natural Biocon (India) balance sheet

₹ crore, at each year end.

Natural Biocon (India) Balance sheet
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	11.39	11.40	11.40	11.38	11.38	11.39	11.38	11.38	11.38	25.75	25.74
Reserves	0.00	0.00	0.63	0.63	0.60	0.60	0.67	0.85	1.00	6.07	4.93
Borrowings	0.00	0.00	0.00	0.83	0.69	0.37	0.17	0.16	0.08	0.29	0.39
Other Liabilities	0.03	0.13	0.42	0.20	0.04	0.04	0.08	1.13	4.32	6.33	5.70
Total Liabilities	11.42	11.53	12.45	13.04	12.71	12.40	12.30	13.52	16.78	38.44	36.76
Fixed Assets	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CWIP	3.30	3.30	3.30	3.30	3.30	3.30	3.30	3.30	3.30	3.30	3.30
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	21.02	21.03
Other Assets	8.12	8.23	9.15	9.74	9.41	9.10	9.00	10.22	13.48	14.12	12.43
Inventories	0.08	0.05	0.05	0.05	0.05	0.05	0.05	0.91	0.15	0.16	0.00
Trade receivables	0.00	0.00	1.01	0.77	0.61	0.51	0.48	0.62	4.86	5.65	5.13
Cash & equivalents	0.09	0.23	0.12	0.02	0.02	0.03	0.20	0.39	0.18	0.04	0.03
Total Assets	11.42	11.53	12.45	13.04	12.71	12.40	12.30	13.52	16.78	38.44	36.76

Natural Biocon (India) cash flow

₹ crore, for each year.

Natural Biocon (India) Cash flow
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	0.03	0.20	−0.03	−0.85	0.14	0.31	0.17	0.20	−0.11	1.29	0.02
Cash from investing activity	0.00	0.00	0.00	0.00	0.00	0.00	−0.02	0.00	0.00	−21.15	−0.14
Cash from financing activity	0.00	−0.08	−0.08	0.76	−0.15	−0.33	0.00	−0.03	−0.10	19.72	0.10
Net cash flow	0.05	0.16	−0.12	−0.12	0.02	0.00	0.18	0.20	−0.22	−0.15	−0.02
Capex	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01
Free cash flow	0.03	0.20	−0.03	−0.85	0.14	0.31	0.16	0.20	−0.11	1.29	0.00
CFO / OP %	—	218.0%	26.1%	−735.9%	−500.0%	—	222.1%	112.0%	−22.0%	2,200.0%	−75.0%

Natural Biocon (India) ratios

Working-capital days and returns, by year.

Natural Biocon (India) Ratios
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	0	0	357	632	—	1,459	372	183	130	246	735
Inventory days	822	548	—	—	—	—	—	383	6	9	0
Days payable	0	0	—	—	—	—	—	423	118	270	—
Cash conversion cycle	822	548	359	634	—	1,461	374	143	19	−13	737
Working capital days	7,666	2,240	573	682	—	3,819	358	135	50	16	−131
ROCE %	—	1.0%	8.6%	1.0%	−0.2%	0.0%	0.7%	2.0%	1.9%	0.3%	−0.1%

Natural Biocon (India): frequently asked questions

What are the latest quarterly results of Natural Biocon (India)?

For the Mar 2026 quarter, Natural Biocon (India) reported sales of ₹0.89 Cr, down 34.6% year on year and net profit of −₹0.10 Cr. The operating margin was −10.2%.

What is the annual revenue of Natural Biocon (India)?

Natural Biocon (India)'s sales for the year to Mar 2026 were ₹2.56 Cr; over the last twelve months they were ₹2.57 Cr.

What is the net profit of Natural Biocon (India)?

Net profit for the year to Mar 2026 was −₹0.05 Cr, and −₹0.05 Cr over the last twelve months. Earnings per share over the same trailing period were ₹−0.04.

How much debt does Natural Biocon (India) have?

Natural Biocon (India) reported borrowings of ₹0.39 Cr at Mar 2026, against cash and equivalents of ₹0.03 Cr.

What is the free cash flow of Natural Biocon (India)?

Cash from operations was ₹0.02 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹0 Cr.

Loading…